UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study

Multiple sclerosis, 2011-07, Vol.17 (7), p.867-875

2011

Volltextzugriff (PDF)

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

Multiple sclerosis, 2016-11, Vol.22 (13), p.1719-1731

2016

Volltextzugriff (PDF)

An excessive risk of suicide may no longer be a reality for multiple sclerosis patients

Multiple sclerosis, 2017-05, Vol.23 (6), p.864-871

2017

Volltextzugriff (PDF)

‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study

Multiple sclerosis, 2013-04, Vol.19 (4), p.458-465

2013

Volltextzugriff (PDF)

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

Multiple sclerosis, 2016-04, Vol.22 (4), p.533-543

2016

Volltextzugriff (PDF)

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

Journal of evidence-based integrative medicine, 2018-01, Vol.23, p.2515690X18806269-2515690X18806269

2018

Volltextzugriff (PDF)

Focal and diffuse cervical spinal cord damage in patients with early relapsing–remitting MS: A multicentre magnetisation transfer ratio study

Multiple sclerosis, 2019-07, Vol.25 (8), p.1113-1123

2019

Volltextzugriff (PDF)

Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials

Multiple sclerosis, 2019-04, Vol.25 (4), p.565-573

2019

Volltextzugriff (PDF)

Long-term survival of patients with multiple sclerosis in West France

Multiple sclerosis, 2007-08, Vol.13 (7), p.865-874

2007

Volltextzugriff (PDF)

Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease

Multiple sclerosis, 2016-05, Vol.22 (6), p.817-821

2016

Volltextzugriff (PDF)

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

Multiple sclerosis, 2012-10, Vol.18 (10), p.1466-1471

2012

Volltextzugriff (PDF)

Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome

Multiple sclerosis, 2016-07, Vol.22 (8), p.1032-1039

2016

Volltextzugriff (PDF)

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis

Multiple sclerosis, 2002-10, Vol.8 (5), p.441-445

2002

Volltextzugriff (PDF)

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

Multiple sclerosis, 2012-07, Vol.18 (7), p.966-973

2012

Volltextzugriff (PDF)

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome

Multiple sclerosis, 2014-02, Vol.20 (2), p.234-242

2014

Volltextzugriff (PDF)

Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis

Multiple sclerosis, 2011-12, Vol.17 (12), p.1504-1513

2011

Volltextzugriff (PDF)

The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing–remitting multiple sclerosis

Multiple sclerosis, 2009-02, Vol.15 (2), p.238-243

2009

Volltextzugriff (PDF)

Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosis

Multiple sclerosis, 2004-08, Vol.10 (4), p.407-412

2004

Volltextzugriff (PDF)

Safety and Tolerability of a ‘Refrigeration-free’ Formulation of Interferon Beta-1b - Results of a Double-blind, Multicentre, Comparative Study in Patients with Relapsing-Remitting or Secondary Progressive Multiple Sclerosis

Journal of international medical research, 2006-01, Vol.34 (1), p.1-12

Baum, K

2006

Volltextzugriff (PDF)

Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data

Multiple sclerosis, 2001-06, Vol.7 (3), p.179-183

2001

Volltextzugriff (PDF)

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

Multiple sclerosis, 2013-09, Vol.19 (10), p.1310-1319

2013

Volltextzugriff (PDF)

Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis

Multiple sclerosis, 2008-04, Vol.14 (3), p.399-405

2008

Volltextzugriff (PDF)

Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required

Multiple sclerosis, 2009-11, Vol.15 (11), p.1303-1310

2009

Volltextzugriff (PDF)

Comparative study of mitoxantrone efficacy profile in patients with relapsing—remitting and secondary progressive multiple sclerosis

Multiple sclerosis, 2010-12, Vol.16 (12), p.1490-1499

2010

Volltextzugriff (PDF)

Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis

Multiple sclerosis, 2012-04, Vol.18 (4), p.418-424

2012

Volltextzugriff (PDF)

1 – 25 von 756

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Complete A-Z List

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(756)
Mit Volltextzugriff
(748)

Publikationsform

Artikel
(756)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(756)
SAGE Journals
(756)
IngentaConnect Journals
(112)
Ovid Journals
(77)
EZB Free E-Journals
(21)
Applied Social Sciences Index & Abstracts (ASSIA)
(16)
Ingenta Connect
(8)
Wiley-Blackwell Journals
(6)
Taylor & Francis Online
(4)
Taylor & Francis Journals Auto-Holdings Collection
(4)
Single Journals
(3)
ERIC
(2)
JSTOR Complete Journals
(2)
BMJ
(2)
Elsevier ScienceDirect Journals Complete
(2)
Sociological Abstracts
(1)

11 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

An excessive risk of suicide may no longer be a reality for multiple sclerosis patients

‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

Focal and diffuse cervical spinal cord damage in patients with early relapsing–remitting MS: A multicentre magnetisation transfer ratio study

Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials

Long-term survival of patients with multiple sclerosis in West France

Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome

Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis

The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing–remitting multiple sclerosis

Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosis

Safety and Tolerability of a ‘Refrigeration-free’ Formulation of Interferon Beta-1b - Results of a Double-blind, Multicentre, Comparative Study in Patients with Relapsing-Remitting or Secondary Progressive Multiple Sclerosis

Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis

Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required

Comparative study of mitoxantrone efficacy profile in patients with relapsing—remitting and secondary progressive multiple sclerosis

Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis

Aktive Filter

Suchergebnisse filtern